Magenta Life (544188)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹39.85 |
| Market Cap | ₹27.38 Cr |
| P/E Ratio | 94.1 |
| ROCE | 2.61% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 25% |
| Debt/Equity | — |
| Sales Growth | -6.85% |
| 52-Week Range | ₹8.5 — ₹39.85 |
| Sector | Consumer Durables |
Strengths
- Piotroski F-Score of 6/9 suggests acceptable short-term financial health.
- Profit growth of 25% shows some earnings momentum, albeit from a low base.
- Stock is trading at the top of its 52-week range, reflecting strong market optimism.
- Latest quarter sales of ₹5 Cr confirm an active operating business, though small.
Concerns
- P/E of 94.10 with declining sales and ROCE of only 2.61% implies extreme valuation.
- Latest quarter net profit of ₹0 Cr means concrete earnings power is not yet visible.
- Sales declined 6.85%, so there is no evidence of a durable top-line recovery.
- Critical data like promoter holding, book value, and debt-to-equity are missing, making fundamental analysis incomplete.
AI Analysis
At ₹39.85, Magenta Life carries a market cap of just ₹27 crore. The market is asking me to pay 94 times earnings for a furniture business whose sales fell 6.85% and whose latest quarter produced a net profit of roughly ₹0 crore. That is not value investing; that is speculation. The ROCE of 2.61% tells me the capital employed in this business is not generating a meaningful return. The 25% profit growth may look encouraging, but when the base is this thin, percentage growth can mislead. The Piotroski F-Score of 6/9 offers some comfort on financial health, but with promoter holding, book value, and debt-to-equity all unavailable, I cannot perform the margin-of-safety analysis Graham demanded. The stock has already run from ₹8.50 to ₹39.85, so Mr. Market has priced in a dramatic recovery. A PEG of 3.76 shows the valuation is not cheap even if that 25% growth were to continue. The zero dividend means I receive no income while waiting for a turnaround that may or may not come. In my circle, I prefer businesses with pricing power, high returns on capital, and transparent disclosures. Magenta Life currently shows none of those in sufficient quantity. It might be a turnaround candidate, but turnarounds rarely turn smoothly. I would need sustained quarterly profits, positive sales growth, and a far lower price before this becomes an investment. For now, this belongs in the 'too hard' pile.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer